Market by Product Type, Gender, Application, End-user, and Country Outlook | Forecast 2023-2030
Triton Market Research’s report estimates that the North America botulinum toxin market is set to progress with a compound annual growth rate of 9.78% during the forecast years 2023-2030.
Report scope can be customized per your requirements - Request Free Sample Report
The
countries explored in the region are:
•
United States
•
Canada
The market’s growth in the region is driven by
the increasing adoption of cosmetic procedures, and a rise in consumer expenditure. Moreover, the growing demand for minimally
invasive or noninvasive treatments like glabellar lines and chemical browlifts
further drives the studied market. Statistics reveal that the United States
witnessed the highest number of cosmetic procedures globally in 2020. As of
2022, approximately 7.5 million individuals in the US have undergone botox
treatments.
The US
leads with the major market share in the region. Along with the factors mentioned above, the rapid progress in medical
aesthetic technology boosts the market’s growth immensely. These advanced
technologies have provided diverse options and remedies for individuals needing
medical support. As per estimates, botulinum injection, utilized to address
facial wrinkles, is the most common cosmetic procedure across the United
States. As a result, the utilization of botulinum toxins for aesthetic
treatments contributes heavily to the studied market’s development.
Furthermore, several individuals in Canada are
opting for minimally invasive cosmetic treatments to diminish facial wrinkles
and enhance their looks. In this regard, the administration of botulinum
neurotoxin via injection serves both medical and aesthetic objectives. Within
Canada, patients have access to three variants of botulinum toxin, namely botulinum
toxin type A, commercially known as Botox, Xeomin, and Dysport. This
significantly supports the market’s growth across the nation.
The popularity of non-surgical facial
rejuvenation procedures is on the rise. Moreover, the landscape of facial
rejuvenation has been significantly altered by the aesthetic applications of
botulinum toxin, leading to a dramatic transformation. Currently, the
utilization of botulinum toxin (BoNT) for cosmetic purposes stands as the most
frequently performed cosmetic procedure worldwide. BoNT offers a diverse range
of cosmetic benefits, including treating glabellar lines, chemical browlifts,
forehead wrinkles, and periorbital and perioral lines.
The
market’s development is assessed in terms of application, gender, product type,
and end-user. The
application category further includes aesthetic and medical.
The
leading companies listed in the market’s report include Evolus Inc, AbbVie Inc,
Medytox Inc, Daewoong Pharmaceutical Co Ltd, and Galderma SA.
Evolus Inc is engaged in supplying medical
aesthetic goods to doctors and patients. The company’s product lineup includes
Jeuveau®, a 900-kilodalton purified botulinum toxin type A formula that treats
adults, temporarily enhancing moderate to severe glabellar lines. Established in
2012, the company is headquartered in Newport Beach, California.
Key deliverables of the report:
●
Market CAGR during the forecasting years 2023-2030
●
Detailed data highlighting key insights, industry components, and
market strategies
●
Comprehensive information and estimation of the botulinum toxin
market revenue growth in North America and its influence on the parent market
●
In-depth study of forthcoming trends in consumer behavioral
patterns
●
A meticulous analysis of the competitive landscape, vendor
scorecard, and Porter’s Five Forces
●
A wide-ranging study of factors that will challenge the NA
botulinum toxin market’s growth during the upcoming years
Want to get specific insights? Our team of analysts
can customize this report based on your preferences. Connect with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. NORTH
AMERICA BOTULINUM TOXIN MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
ANALYSIS ON THE BOTULINUM TOXIN MARKET
2.1.1. COVID-19
IMPACT
2.2. KEY
INSIGHTS
2.2.1. GROWING
DEMAND FOR NON-INVASIVE COSMETIC PROCEDURES
2.2.2. SURGE
IN DEMAND FOR BOTULINUM TOXIN AMONG MILLENNIALS
AND
GEN-Z
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. REGULATORY
FRAMEWORK
2.5. KEY
MARKET STRATEGIES
2.5.1. PRODUCT
LAUNCHES
2.5.2. COLLABORATIONS
2.5.3. BUSINESS
EXPANSIONS & DIVESTITURES
2.5.4. ACQUISITIONS
2.6. MARKET
DRIVERS
2.6.1. SURGE
IN DEMAND FOR AESTHETIC PROCEDURES
2.6.2. RISE
IN GERIATRIC POPULATION
2.7. MARKET
CHALLENGES
2.7.1. LIMITED
REIMBURSEMENT POLICIES SUPPORTING COSMETIC PROCEDURES
2.7.2. ADVERSE
EFFECTS OF BOTULINUM TOXIN
2.7.3. EMERGING
PROBLEM OF BOTULINUM TOXIN TYPE A RESISTANCE
2.8. MARKET
OPPORTUNITIES
2.8.1. EXPANSION
OF BOTULINUM TOXIN INTO THERAPEUTIC APPLICATIONS
2.8.2. RISING
MEDICAL TOURISM
2.9. ANALYST
PERSPECTIVE
3. NORTH
AMERICA BOTULINUM TOXIN MARKET OUTLOOK - BY PRODUCT TYPE
3.1. TYPE A
BOTULINUM TOXIN
3.2. TYPE B
BOTULINUM TOXIN
4. NORTH
AMERICA BOTULINUM TOXIN MARKET OUTLOOK - BY GENDER
4.1. WOMEN
4.2. MEN
5. NORTH
AMERICA BOTULINUM TOXIN MARKET OUTLOOK - BY APPLICATION
5.1. AESTHETIC
5.1.1. CROW’S
FEET
5.1.2. FOREHEAD
LINES
5.1.3. FROWN
LINES/GLABELLAR
5.1.4. SQUARE
JAW/MASSETER
5.1.5. OTHER
AESTHETIC APPLICATIONS
5.2. MEDICAL
5.2.1. CHRONIC
MIGRAINE
5.2.2. MUSCLE
SPASM
5.2.3. OVERACTIVE
BLADDER
5.2.4. HYPERHIDROSIS
5.2.5. OTHER
MEDICAL APPLICATIONS
6. NORTH
AMERICA BOTULINUM TOXIN MARKET OUTLOOK - BY END-USER
6.1. SPECIALTY
AND DERMATOLOGY CLINICS
6.2. HOSPITALS
AND CLINICS
6.3. OTHER
END-USERS
7. NORTH
AMERICA BOTULINUM TOXIN MARKET – BY COUNTRY OUTLOOK
7.1. NORTH
AMERICA
7.1.1. MARKET
BY PRODUCT TYPE
7.1.2. MARKET
BY GENDER
7.1.3. MARKET
BY APPLICATION
7.1.3.1. MARKET
BY AESTHETIC
7.1.3.2. MARKET
BY MEDICAL
7.1.4. MARKET
BY END-USER
7.1.5. COUNTRY
ANALYSIS
7.1.5.1. UNITED
STATES
7.1.5.1.1. UNITED
STATES BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
7.1.5.2. CANADA
7.1.5.2.1. CANADA
BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
8. COMPETITIVE
LANDSCAPE
8.1. ABBVIE
INC
8.1.1. OVERVIEW
8.1.2. PRODUCT
PORTFOLIO
8.1.3. KEY
STRENGTHS
8.1.4. KEY
CHALLENGES
8.2. EVOLUS
INC
8.2.1. OVERVIEW
8.2.2. PRODUCT
PORTFOLIO
8.2.3. KEY
STRENGTHS
8.2.4. KEY
CHALLENGES
8.3. MEDYTOX
INC
8.3.1. OVERVIEW
8.3.2. PRODUCT
PORTFOLIO
8.3.3. KEY
STRENGTHS
8.3.4. KEY
CHALLENGES
8.4. LANZHOU
INSTITUTE OF BIOLOGICAL PRODUCTS CO LTD
8.4.1. OVERVIEW
8.4.2. PRODUCT
PORTFOLIO
8.4.3. KEY
STRENGTHS
8.4.4. KEY
CHALLENGES
8.5. DAEWOONG
PHARMACEUTICAL CO LTD
8.5.1. OVERVIEW
8.5.2. PRODUCT
PORTFOLIO
8.5.3. KEY
STRENGTHS
8.5.4. KEY
CHALLENGES
8.6. GALDERMA
SA
8.6.1. OVERVIEW
8.6.2. PRODUCT
PORTFOLIO
8.6.3. KEY
STRENGTHS
8.6.4. KEY
CHALLENGES
8.7. IPSEN
PHARMA
8.7.1. OVERVIEW
8.7.2. PRODUCT
PORTFOLIO
8.7.3. KEY
STRENGTHS
8.7.4. KEY
CHALLENGES
8.8. HUGEL
INC
8.8.1. OVERVIEW
8.8.2. PRODUCT
PORTFOLIO
8.8.3. KEY
STRENGTHS
8.8.4. KEY
CHALLENGES
8.9. CANDELA
MEDICAL CORPORATION
8.9.1. OVERVIEW
8.9.2. PRODUCT
PORTFOLIO
8.9.3. KEY
STRENGTHS
8.9.4. KEY
CHALLENGES
8.10. MERZ
PHARMA GMBH & CO KGAA
8.10.1. OVERVIEW
8.10.2. PRODUCT
PORTFOLIO
8.10.3. KEY
STRENGTHS
8.10.4. KEY
CHALLENGES
8.11. REVANCE
THERAPEUTICS INC
8.11.1. OVERVIEW
8.11.2. PRODUCT
PORTFOLIO
8.12. US
WORLDMEDS LLC
8.12.1. OVERVIEW
8.12.2. PRODUCT
PORTFOLIO
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.2. SOURCES
OF DATA
9.3. RESEARCH
METHODOLOGY
TABLE 1: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 2: NORTH AMERICA
REGULATORY FRAMEWORK FOR BOTULINUM TOXIN
TABLE 3: LIST OF PRODUCT
LAUNCHES
TABLE 4: LIST OF
COLLABORATIONS
TABLE 5: LIST OF BUSINESS
EXPANSIONS & DIVESTITURES
TABLE 6: LIST OF ACQUISITIONS
TABLE 7: EXAMPLE OF
COMMERCIALLY AVAILABLE BOTULINUM TOXIN TYPE A FOR AESTHETIC PROCEDURES
TABLE 8: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY PRODUCT TYPE, 2023-2030 (IN $ MILLION)
TABLE 9: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY GENDER, 2023-2030 (IN $ MILLION)
TABLE 10: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY APPLICATION, 2023-2030 (IN $ MILLION)
TABLE 11: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY AESTHETIC, 2023-2030 (IN $ MILLION)
TABLE 12: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY MEDICAL, 2023-2030 (IN $ MILLION)
TABLE 13: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE 14: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
FIGURE 1: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY PRODUCT TYPE, 2022 & 2030 (IN %)
FIGURE 2: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY TYPE A BOTULINUM TOXIN, 2023-2030 (IN $ MILLION)
FIGURE 3: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY TYPE B BOTULINUM TOXIN, 2023-2030 (IN $ MILLION)
FIGURE 4: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY GENDER, 2022 & 2030 (IN %)
FIGURE 5: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY WOMEN, 2023-2030 (IN $ MILLION)
FIGURE 6: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY MEN, 2023-2030 (IN $ MILLION)
FIGURE 7: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY APPLICATION, 2022 & 2030 (IN %)
FIGURE 8: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY AESTHETIC, 2023-2030 (IN $ MILLION)
FIGURE 9: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY AESTHETIC, 2022 & 2030 (IN %)
FIGURE 10: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY CROW’S FEET, 2023-2030 (IN $ MILLION)
FIGURE 11: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY FOREHEAD LINES, 2023-2030 (IN $ MILLION)
FIGURE 12: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY FROWN LINES/GLABELLAR, 2023-2030 (IN $ MILLION)
FIGURE 13: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY SQUARE JAW/MASSETER, 2023-2030 (IN $ MILLION)
FIGURE 14: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY OTHER AESTHETIC APPLICATIONS, 2023-2030 (IN $
MILLION)
FIGURE 15: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY MEDICAL, 2023-2030 (IN $ MILLION)
FIGURE 16: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY MEDICAL, 2022 & 2030 (IN %)
FIGURE 17: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY CHRONIC MIGRAINE, 2023-2030 (IN $ MILLION)
FIGURE 18: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY MUSCLE SPASM, 2023-2030 (IN $ MILLION)
FIGURE 19: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY OVERACTIVE BLADDER, 2023-2030 (IN $ MILLION)
FIGURE 20: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY HYPERHIDROSIS, 2023-2030 (IN $ MILLION)
FIGURE 21: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY OTHER MEDICAL APPLICATIONS, 2023-2030 (IN $ MILLION)
FIGURE 22: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY END-USER, 2022 & 2030 (IN %)
FIGURE 23: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY SPECIALTY AND DERMATOLOGY CLINICS, 2023-2030 (IN $
MILLION)
FIGURE 24: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY HOSPITALS AND CLINICS, 2023-2030 (IN $ MILLION)
FIGURE 25: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY OTHER END-USERS, 2023-2030 (IN $ MILLION)
FIGURE 26: NORTH AMERICA
BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2022 & 2030 (IN %)
FIGURE 27: UNITED STATES
BOTULINUM TOXIN MARKET 2023-2030 (IN $ MILLION)
FIGURE 28: CANADA BOTULINUM
TOXIN MARKET 2023-2030 (IN $ MILLION)